2014
DOI: 10.1002/humu.22520
|View full text |Cite
|
Sign up to set email alerts
|

Prioritizing Disease-Linked Variants, Genes, and Pathways with an Interactive Whole-Genome Analysis Pipeline

Abstract: Whole genome sequencing (WGS) studies are uncovering disease-associated variants in both rare and non-rare diseases. Utilizing the next-generation sequencing for WGS requires a series of computational methods for alignment, variant detection, and annotation, and the accuracy and reproducibility of annotation results are essential for clinical implementation. However, annotating WGS with up to date genomic information is still challenging for biomedical researchers. Here we present one of the fastest and highly… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 25 publications
(25 citation statements)
references
References 80 publications
0
25
0
Order By: Relevance
“…DisGeNET platform has been used to study a variety of biomedical problems, which include investigating the molecular basis of specific diseases (3336), annotating lists of genes produced by different types of omics and sequencing protocols (3739), validating disease genes prediction methods (4042), understanding disease mechanisms in the context of protein networks (43,44), gaining insight into drug action (45) and drug adverse reactions mechanisms (46), drug repurposing (47), exploring the molecular basis of disease comorbidities (48,49), assessing the performance of text-mining algorithms (50) and as part of other resources (5153). …”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…DisGeNET platform has been used to study a variety of biomedical problems, which include investigating the molecular basis of specific diseases (3336), annotating lists of genes produced by different types of omics and sequencing protocols (3739), validating disease genes prediction methods (4042), understanding disease mechanisms in the context of protein networks (43,44), gaining insight into drug action (45) and drug adverse reactions mechanisms (46), drug repurposing (47), exploring the molecular basis of disease comorbidities (48,49), assessing the performance of text-mining algorithms (50) and as part of other resources (5153). …”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…com) or the gNOME project pipeline (http://gnome.tchlab. org/) [29]. Identified variants in the pre-selected candidate genes (Additional file 1) were then reviewed for presence/ absence and frequency in various websites including dbSNP (http://www.ncbi.nlm.nih.gov/snp/), 1000 genomes (http:// www.1000genomes.org/), and the Exome Variant Server database (http://evs.gs.washington.edu/EVS/).…”
Section: Exome Variant Analysismentioning
confidence: 99%
“…Recently, many efforts have been made toward developing graphical tools to process VCF files for researchers with limited bioinformatics background. Tools like SNVerGUI (W. Wang, Hu, Hou, Hu, & Wei, ), database.bio (Ou et al, ), DaMold (Pandey, Pabinger, Kriegner, & Weinhausel, ), mirVAFC (Li et al, ), GAVIN (van der Velde et al, ), and gNOME (Lee et al, ) have been developed to help nonbioinformaticians prioritize variants. However, they share the disadvantage of depending on a well‐defined set of annotations, discarding user‐defined annotations in VCFs and thus limiting the user to predefined features.…”
Section: Introductionmentioning
confidence: 99%